Apr 6, 2024, 07:42
Early-stage triple-negative breast cancer treated with locoregional therapy only – JAMA Oncology
JAMA Oncology shared on X/Twitter:
“In patients with early-stage triple-negative breast cancer treated with locoregional therapy only, higher levels of tumor-infiltrating lymphocytes in breast cancer tissue were associated with improved survival.”
Visit the article website.
Source: JAMA Oncology/X
Aug 27, 2024, 03:21